Digital health RCT interventions for cardiovascular disease risk reduction: a systematic review and meta-analysis

Rohan Neil Devani1, Arushan Kirubakaran1, Mariam Molokhia1

  • 1Department of Life Sciences and Medicine, King's College London, Great Maze Pond, London, SE1 1UL UK.

Health and Technology
|March 30, 2022
PubMed

Insights

Digital health interventions (DHIs) show inconclusive effects on cardiovascular disease risk scores. Automated email messaging may be effective, but more research is needed due to study heterogeneity and bias concerns.

Area of Science:

  • Cardiology
  • Digital Health
  • Public Health

Background:

  • Heart disease is a major cause of mortality in the UK.
  • Digital health interventions (DHIs) show potential for reducing cardiovascular risk.
  • Recent reviews on DHIs for cardiovascular disease (CVD) risk are lacking.

Purpose of the Study:

  • To examine the effect of DHIs on cardiovascular disease (CVD) risk scores in high-risk patients.
  • To compare DHIs combined with usual care against usual care alone.
  • To identify effective DHI modalities for managing CVD risk.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) published after 2010.
  • Searches conducted in PubMed, Cochrane Database, Medline, and Google Scholar.
  • Primary outcome: change in CVD risk score (e.g., QRISK3); risk-of-bias assessed using Cochrane RoB-2 tool.

Main Results:

  • Six RCTs involving 1,157 patients in DHI groups and 1,127 in control groups were included.
  • Meta-analysis showed an inconclusive overall effect for DHIs (MD -0.76, 95% CI -1.72, 0.20).
  • Automated email messaging showed potential effectiveness (MD -1.09, 95% CI -2.15, -0.03), but heterogeneity (I²=66%) and bias concerns were noted.

Conclusions:

  • Overall DHIs had an inconclusive effect on cardiovascular disease risk scores.
  • Specific DHIs, like automated email messaging, may offer benefits.
  • Further research with longer follow-up is needed to clarify the efficacy of specific DHI modalities.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
60
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
101
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
90
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
493